Stryker Seeks Exemption For Patient-Transport Devices
A petition submitted to the US FDA seeks to exempt class II powered patient-transport devices from premarket notification requirements.
You may also be interested in...
The US agency didn’t buy Stryker’s argument in its April petition that there is no data suggesting patient-transport devices have a history of false and misleading claims.
The US FDA has granted its breakthrough designation to a virtual reality therapy that recreates everyday scenarios for patients dealing with severe anxiety and schizophrenia.
The US House of Representatives overwhelmingly passed legislation authorizing the creation of a federal health agency to advance biomedical research. The bill now goes to the Senate.